These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31918110)

  • 1. Identifying targets of potential concern by a screening level ecological risk assessment of human use pharmaceuticals in China.
    Bu Q; Cao Y; Yu G; He X; Zhang H; Sun J; Yun M; Cao Z
    Chemosphere; 2020 May; 246():125818. PubMed ID: 31918110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
    Liebig M; Moltmann JF; Knacker T
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting variability of aquatic concentrations of human pharmaceuticals.
    Kostich MS; Batt AL; Glassmeyer ST; Lazorchak JM
    Sci Total Environ; 2010 Sep; 408(20):4504-10. PubMed ID: 20619877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
    Kosma CI; Lambropoulou DA; Albanis TA
    Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical evaluation of different parameters for estimating pharmaceutical exposure seeking an improved environmental risk assessment.
    Pereira AMPT; Silva LJG; Lino CM; Meisel LM; Pena A
    Sci Total Environ; 2017 Dec; 603-604():226-236. PubMed ID: 28628814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation.
    Kostich MS; Batt AL; Lazorchak JM
    Environ Pollut; 2014 Jan; 184():354-9. PubMed ID: 24095705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecological impact of pharmaceutical pollutants and options of river health improvements - A risk analysis-based approach.
    Singh PK; Ranjan N
    Sci Total Environ; 2024 Jun; 928():172358. PubMed ID: 38614331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the data gap: What do we know about environmental exposure, hazards and risks of pharmaceuticals in the European aquatic environment?
    Spilsbury FD; Inostroza PA; Svedberg P; Cannata C; Ragas AMJ; Backhaus T
    Water Res; 2024 Mar; 251():121002. PubMed ID: 38309057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a risk for the aquatic environment due to the existence of emerging organic contaminants in treated domestic wastewater? Greece as a case-study.
    Thomaidi VS; Stasinakis AS; Borova VL; Thomaidis NS
    J Hazard Mater; 2015; 283():740-7. PubMed ID: 25464317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human health and ecological risk assessment of 98 pharmaceuticals and personal care products (PPCPs) detected in Indian surface and wastewaters.
    Sengar A; Vijayanandan A
    Sci Total Environ; 2022 Feb; 807(Pt 1):150677. PubMed ID: 34599960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and ecological risk assessment of pharmaceuticals and personal care products in Taihu Lake, China: a review.
    Nkoom M; Lu G; Liu J
    Environ Sci Process Impacts; 2018 Dec; 20(12):1640-1648. PubMed ID: 30346017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The removal of pharmaceuticals during wastewater treatment: Can it be predicted accurately?
    Comber S; Gardner M; Sörme P; Ellor B
    Sci Total Environ; 2019 Aug; 676():222-230. PubMed ID: 31048154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of metabolites in the environmental risk assessment of pharmaceuticals consumed by human.
    Han EJ; Lee DS
    Sci Total Environ; 2017 Aug; 592():600-607. PubMed ID: 28318699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of predicted environmental concentrations to prioritize the occurrence of pharmaceuticals in rivers from Catalonia.
    Gómez-Canela C; Pueyo V; Barata C; Lacorte S; Marcé RM
    Sci Total Environ; 2019 May; 666():57-67. PubMed ID: 30784823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
    Gros M; Petrović M; Ginebreda A; Barceló D
    Environ Int; 2010 Jan; 36(1):15-26. PubMed ID: 19819553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of priority pharmaceuticals in the water environment of China.
    Sui Q; Wang B; Zhao W; Huang J; Yu G; Deng S; Qiu Z; Lu S
    Chemosphere; 2012 Sep; 89(3):280-6. PubMed ID: 22591850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical environmental risk assessment of ten used pharmaceuticals in Belo Horizonte, Brazil.
    Neves AC; Mol MPG
    Environ Monit Assess; 2019 Apr; 191(5):275. PubMed ID: 30976940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major pharmaceuticals and personal care products (PPCPs) in wastewater treatment plant and receiving water in Beijing, China, and associated ecological risks.
    Dai G; Huang J; Chen W; Wang B; Yu G; Deng S
    Bull Environ Contam Toxicol; 2014 Jun; 92(6):655-61. PubMed ID: 24619361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern.
    Blair BD; Crago JP; Hedman CJ; Klaper RD
    Chemosphere; 2013 Nov; 93(9):2116-23. PubMed ID: 23973285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.